Skip to main content
. 2016 Jul 4;6:28948. doi: 10.1038/srep28948

Figure 3. qRT-PCR validation of DHC2 and KIF2B expression in temozolomide-treated cells.

Figure 3

Expression of DHC2 and KIF2B mRNA was detected in GBM cells treated with 200 μM temozolomide or DMSO for one to two weeks using qRT-PCR (*P < 0.05 and **P < 0.01).